PHAL
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.
Lue lisääEPS (oik.)
Osinko %
Yhtiökokous '26
Osavuosikatsaus Q2'26
Osavuosikatsaus Q3'26